
In five to ten years China could become a world leader in therapeutic cloning and related research, a US stem cell scientist has predicted in the journal Nature. Xiangzhong Yang, of the University of Connecticut, contends that China's main asset is that it lacks the ethical qualms which have hampered the development of research on human embryos in Western countries. "In addition," he says, "the relatively easy access to human material, including embryonic and foetal tissues, in China is a huge advantage for researchers".
Chinese scientists have already achieved notable progress towards…
MORE